Liu, Hong <br/><br/>
Metabolism and Disposition of a Novel B-Cell Lymphoma-2 Inhibitor Venetoclax in Humans and Characterization of Its Unusual Metabolites.  [electronic resource] 

 -  Drug metabolism and disposition: the biological fate of chemicals  03 2017 
 - 294-305 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase I; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1521-009X 
<br/><br/><label>Standard No.: </label>10.1124/dmd.116.071613  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Absorption, Physiological<br/>Administration, Oral<br/>Antineoplastic Agents--blood<br/>Biotransformation<br/>Bridged Bicyclo Compounds, Heterocyclic--blood<br/>Feces--chemistry<br/>Female<br/>Healthy Volunteers<br/>Humans<br/>Proto-Oncogene Proteins c-bcl-2--antagonists & inhibitors<br/>Sulfonamides--blood<br/>Tissue Distribution